Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study

被引：1

作者：

Villegas, Ana ^{[1
]}

Arrizabalaga, B. ^{[2
]}

Fernandez-lago, C. ^{[3
]}

Mouzo, M. ^{[4
]}

Mayans, Jr ^{[5
]}

Gonalez-Porras, Jr ^{[6
]}

Duarte, Rafael ^{[7
]}

Remacha, Angel Francisco ^{[8
]}

Luno, Elisa ^{[9
]}

Gasquet, J. A.

机构：

[1] Hosp Clin San Carlos, Madrid, Spain

[2] Hosp Cruces, Dept Haematol, Bilbao, Spain

[3] Hosp Juan Canalejo, Dept Haematol, La Coruna, Spain

[4] Complejo HU Vigo Xeral Cies, Dept Haematol, Vigo, Spain

[5] Hosp Arnau Vilanova, Dept Haematol, Valencia, Spain

[6] Hosp Univ Salamanca, Salamanca, Spain

[7] Hosp Duran & Reynals ICO, Bellvitge, Spain

[8] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[9] Hosp Univ Cent Asturias, Oviedo, Spain

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

10.1182/blood.V112.11.3451.3451

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1184 / 1184

页数：1

共 50 条

[41] Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study [J].

Platzbecker, Uwe ;

Germing, Ulrich ;

Giagounidis, Aristoteles ;

Goetze, Katharina ;

Kiewe, Philipp ;

Mayer, Karin Tina ;

Ottmann, Oliver ;

Radsak, Markus ;

Wolff, Thomas ;

Haase, Detlef ;

Hankin, Monty ;

Wilson, Dawn ;

Zhang, Xiaosha ;

Laadem, Abderrahmane ;

Sherman, Matthew L. ;

Attie, Kenneth M. .

BLOOD, 2015, 126 (23)

[42] LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM THE PHASE 2 PACE-MDS STUDY [J].

Platzbecker, U. ;

Germing, U. ;

Giagounidis, A. ;

Goetze, K. ;

Kiewe, P. ;

Mayer, K. ;

Ottmann, O. ;

Radsak, M. ;

Wolff, T. ;

Haase, D. ;

Hankin, M. ;

Wilson, D. ;

Zhang, X. ;

Laadem, A. ;

Sherman, M. ;

Attie, K. .

HAEMATOLOGICA, 2015, 100 :192-192

[43] A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes [J].

U Platzbecker ;

A Symeonidis ;

E N Oliva ;

J S Goede ;

M Delforge ;

J Mayer ;

B Slama ;

S Badre ;

E Gasal ;

B Mehta ;

J Franklin .

Leukemia, 2017, 31 :1944-1950

[44] A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes [J].

Platzbecker, U. ;

Symeonidis, A. ;

Oliva, E. N. ;

Goede, J. S. ;

Delforge, M. ;

Mayer, J. ;

Slama, B. ;

Badre, S. ;

Gasal, E. ;

Mehta, B. ;

Franklin, J. .

LEUKEMIA, 2017, 31 (09) :1944-1950

[45] Treatment of renal anemia with darbepoetin alfa -: Results of an Austrian multicentre study [J].

Hörl, WH ;

Holzer, H ;

Mayer, GJ .

WIENER KLINISCHE WOCHENSCHRIFT, 2002, 114 (23-24) :967-971

[46] OUTCOMES OF CONTINUED AZACITIDINE TREATMENT FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME IN IPSS LOW AND INTERMEDIATE-1 [J].

Moon, J. H. ;

Sohn, S. K. ;

Cho, Y. Y. ;

Kim, Y. K. ;

Kim, H. J. ;

Kim, M. K. ;

Do, Y. R. ;

Song, M. K. ;

Lee, W. K. ;

Lee, S. M. ;

Kim, H. ;

Won, J. H. ;

Yeon, J. Deok .

HAEMATOLOGICA, 2012, 97 :141-141

[47] The efficacy and safety of darbepoetin alfa for treating anemia in low-risk myelodysplastic syndrome patients: Results after 53/55 weeks. [J].

Gabrilove, Janice ;

Paquette, Ronald ;

Lyons, Roger M. ;

Mushtaq, Chaudhry ;

Sekeres, Mikkael A. ;

Lam, Hung ;

Dreiling, Lyndah .

BLOOD, 2006, 108 (11) :755A-755A

[48] Darbepoetin alfa for the treatment of anemia in patients with myelofibrosis with myeloid metaplasia (MMM). Results from a Danish multicenter study [J].

Hannestad, Kathrine ;

Larsen, Thomas Stauffer ;

Andersen, Torbert Mourits ;

Clausen, Niels Aage Toeffner ;

Hansen, Per Boye ;

Jensen, Bjarne Anker ;

Birgens, Henrik Sverre ;

Hasselbalch, Hans Carl .

BLOOD, 2007, 110 (11) :234B-234B

[49] ACQUISITION OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH IPSS LOW AND INTERMEDIATE-1 RISK. STUDY FROM THE SPANISH GROUP OF MYELODYSPLASTIC SYNDROME [J].

Merchan, B. ;

Ortega, M. ;

Llamas-Poyato, M. J. ;

Cortes, M. ;

Arnan, M. ;

Cervero, C. ;

Montoro, J. ;

Gimenez, T. ;

Lopez, M. ;

Arenillas, L. ;

Valcarcel, D. .

LEUKEMIA RESEARCH, 2015, 39 :S136-S136

[50] BONE MARROW CYTOKINE CHANGES DURING TREATMENT WITH LENALIDOMIDE IN LOW AND INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) [J].

Oliva, N. ;

Ronco, F. ;

Cuzzola, M. ;

Alimena, G. ;

Morabito, F. ;

Spiriti, M. A. Aloe ;

Galimberti, S. ;

Cortelezzi, A. ;

Specchia, G. ;

Poloni, A. ;

Ghio, R. ;

Breccia, M. ;

Finelli, C. ;

Iacopino, P. ;

D'Errigo, Mg ;

Lagana, C. ;

Latagliata, R. ;

Nobile, F. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 :381-381

← 1 2 3 4 5 →